ArticleJournal of the National Comprehensive Cancer Network : JNCCN2025
Sexual Health in Hematopoietic Stem Cell Transplantation Survivors.
Article in Journal of the National Comprehensive Cancer Network : JNCCN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patient-reported outcomes in chronic GVHD: instruments, clinical utility, and survivorship integration.Journal of patient-reported outcomes · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundSexual dysfunction is a common complication affecting the majority of hematopoietic stem cell transplant (HSCT) survivors. However, data on the relationships between sexual health domains, patient-reported quality of life (QoL), and psychological distress remain limited.
methodsWe conducted secondary data analyses of baseline data from 2 randomized sexual health intervention clinical trials involving HSCT survivors who were at least 3 months post-HSCT and reported sexual dysfunction causing distress between February 2019 and February 2023. We assessed sexual health domains (ie, global satisfaction with sex, interest, and function [PROMIS Sexual Function and Satisfaction Measure]), QoL (Functional Assessment of Cancer Therapy - Bone Marrow Transplant), and psychological distress (Hospital Anxiety and Depression Scale) at the time of enrollment. Separate multivariate regression analyses examined the relationships of sexual health domains with QoL and psychological distress.
resultsAmong the 185 enrolled patients (mean [SD] age, 54.8 [14.1] years), 88.1% identified as White, 35.1% identified as female, 83.2% were married or living with someone, and 93.5% identified as heterosexual/straight. Higher global satisfaction with sex was associated with better QoL (B = 0.988; P=.001) and lower depression (B = -0.119; P=.017) and anxiety symptoms (B = -0.124; P=.038). Higher patient-reported interest in sex was associated with better QoL (B = 2.651; P=.001) and lower depression symptoms (B = -0.387; P=.003). Sexual function domains were not associated with psychological distress or QoL, except for orgasm pleasure and erectile dysfunction (males only) (B = 0.277; P=.036), which was associated with QoL.
conclusionsSatisfaction with sex and interest in sex, in contrast to sexual function domains, were associated with QoL and psychological distress in HSCT survivors. These findings underscore that supportive care interventions targeting satisfaction with and interest in sex may serve an important role in improving the QoL and psychological health in this population. Future longitudinal studies should examine causal pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.